Skip to content

Different Methods for Instillation of Drugs which Enhance Lung Function in Preterm Babies

Videolaryngoscopy Versus Direct Laryngoscopy for Less Invasive Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome: A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104921
Enrollment
100
Registered
2026-02-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P220- Respiratory distress syndrome of newborn

Interventions

Intervention1: Video laryngoscopy: Newborns requiring surfactant therapy through less invasive surfactant administration technique with the help of Video laryngoscopy Control Intervention1: Direct Lar

Sponsors

Graphic Era Institute of Medical Sciences
Lead Sponsor
Shantanu Shubham
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Neonates born between 25+0 weeks to 33+6 weeks, diagnosed with respiratory distress syndrome requiring surfactant therapy.

Exclusion criteria

Exclusion criteria: Neonates with congenital airway or heart anomalies, with severe birth asphyxia, with poor respiratory drive.

Design outcomes

Primary

MeasureTime frame
First attempt success rate of complete surfactant administration without repositioning using Video-laryngoscopy assisted LISA VS direct laryngoscopy assisted LISA in preterm newborn with respiratory distress syndrome requiring surfactant administration.Timepoint: First attempt success rate of complete surfactant administration without repositioning using Video-laryngoscopy assisted LISA VS direct laryngoscopy assisted LISA in preterm newborn with respiratory distress syndrome requiring surfactant administration.

Secondary

MeasureTime frame
Complications during procedure, time duration, need of mechanical ventilation and second dose of surfactantTimepoint: Within 7 days of surfactant administration

Countries

India

Contacts

Public ContactSumit Dagar

Graphic Era Institute of Medical Sciences

sumitdagar17@gmail.com8802740007

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026